Mathew Aby J. bought BLFS
March 18, 2025 · Form 4 insider transaction
Mathew Aby J. bought 22,919 shares of BioLife Solutions, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,919
Price
N/A
Total value
N/A
InsiderMathew Aby J.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 18, 2025
Filing dateMarch 20, 2025
Shares owned after283,520
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2025 compensation.